Marco Lupidi
- Ophthalmology top 0.1%
- Retinal Diseases and Treatments 102
- Glaucoma and retinal disorders 53
- Retinal and Optic Conditions 42
- Intraocular Surgery and Lenses 21
- Ocular Diseases and Behçet’s Syndrome 17
-
- Retinal Imaging and Analysis 74
- Retinal and Macular Surgery 16
- Neurology top 10%
-
- Optical Coherence Tomography Applications 12
- Co-authors
- Carlo CaginiFlorence CoscasG. CoscasEric H. SouiedJay ChhablaniTito FioreSumit Randhir SinghAlessandro Invernizzi
- Partner nations
- ItalyFranceUnited States
In The Last Decade
Marco Lupidi
130 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Ophthalmology 2.7k
- Radiology, Nuclear Medicine and Imaging 2.0k
- Neurology 114
- Biomedical Engineering 206
- Public Health, Environmental and Occupational Health 136
Countries citing papers authored by Marco Lupidi
This map shows the geographic impact of Marco Lupidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Lupidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Lupidi more than expected).
Fields of papers citing papers by Marco Lupidi
This network shows the impact of papers produced by Marco Lupidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Lupidi. The network helps show where Marco Lupidi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marco Lupidi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 25 | |
| 9 | 2022 | 19 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 46 | |
| 12 | 2019 | 10 | |
| 13 | 2019 | 88 | |
| 14 | 2017 | 185 | |
| 15 | 2017 | 18 | |
| 16 | 2017 | 7 | |
| 17 | 2016 | 59 | |
| 18 | 2016 | 9 | |
| 19 | 2016 | 27 | |
| 20 | Usual Multimodal Imaging Versus Spectralis “En-Face” OCT 2 Angiography: a new semiologic approach in healthy and AMD patients. | 2015 | 1 |
About Marco Lupidi
Marco Lupidi is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 136 papers that have together received 3.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (102 papers), Retinal Imaging and Analysis (74 papers), Glaucoma and retinal disorders (53 papers), Retinal and Optic Conditions (42 papers), Intraocular Surgery and Lenses (21 papers), Ocular Diseases and Behçet’s Syndrome (17 papers), Retinal and Macular Surgery (16 papers) and Optical Coherence Tomography Applications (12 papers). The work is most often cited by research in Ophthalmology (2.7k citations), Radiology, Nuclear Medicine and Imaging (2.0k citations) and Neurology (114 citations). Marco Lupidi has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Carlo Cagini, Florence Coscas, G. Coscas, Eric H. Souied, Jay Chhablani, Tito Fiore, Sumit Randhir Singh, Alessandro Invernizzi, Daniela Fruttini and G Coscas. Their work appears in journals such as PLoS ONE, Scientific Reports and Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.